KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Current Leases (2019 - 2025)

Exact Sciences (EXAS) has disclosed Current Leases for 11 consecutive years, with $33.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Leases rose 22.59% to $33.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.6 million, a 22.59% increase, with the full-year FY2025 number at $33.6 million, up 22.59% from a year prior.
  • Current Leases was $33.6 million for Q4 2025 at Exact Sciences, up from $31.9 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $33.6 million in Q4 2025 to a low of $15.3 million in Q1 2021.
  • A 5-year average of $26.3 million and a median of $27.3 million in 2024 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: surged 78.86% in 2021, then decreased 10.53% in 2024.
  • Exact Sciences' Current Leases stood at $19.7 million in 2021, then surged by 43.99% to $28.4 million in 2022, then increased by 3.57% to $29.4 million in 2023, then decreased by 6.74% to $27.4 million in 2024, then increased by 22.59% to $33.6 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Current Leases are $33.6 million (Q4 2025), $31.9 million (Q3 2025), and $31.3 million (Q2 2025).